US Stock MarketDetailed Quotes

Ultragenyx Pharmaceutical (RARE)

Watchlist
  • 26.460
  • -0.380-1.42%
Close May 13 15:59 ET
  • 26.460
  • 0.0000.00%
Post 20:01 ET
2.61BMarket Cap-4.34P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ultragenyx Pharmaceutical (RARE) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
-2.16%136M
20.18%673M
25.89%207.28M
14.65%159.93M
13.24%166.5M
27.72%139M
29.03%560M
29.50%164.65M
42.27%139.49M
35.75%147.03M
Operating revenue
-2.16%136M
20.18%673M
25.89%207.28M
14.65%159.93M
13.24%166.5M
27.72%139M
29.03%560M
29.50%164.65M
42.27%139.49M
35.75%147.03M
Cost of revenue
3.45%30M
41.56%109M
70.95%29.35M
33.16%27.99M
8.09%23M
65.40%29M
71.11%77M
44.96%17.17M
91.33%21.02M
114.65%21.28M
Gross profit
-3.64%106M
16.77%564M
20.65%177.93M
11.37%131.94M
14.11%143.49M
20.48%110M
24.16%483M
27.91%147.48M
36.07%118.47M
27.80%125.75M
Operating expense
8.70%275M
7.85%1.1B
7.94%291.22M
20.91%302.83M
3.83%251.38M
-1.42%253M
6.37%1.02B
13.77%269.79M
7.88%250.46M
-1.72%242.11M
Selling and administrative expenses
1.15%88M
8.72%349M
7.39%87.94M
7.80%86.62M
7.50%86.65M
11.31%87M
3.55%321M
6.30%81.89M
7.25%80.35M
-0.98%80.6M
Research and development costs
12.65%187M
7.45%750M
8.18%203.28M
27.10%216.21M
2.00%164.74M
-7.00%166M
7.72%698M
17.36%187.9M
8.18%170.11M
-2.09%161.5M
Operating profit
-18.18%-169M
0.19%-535M
7.38%-113.28M
-29.47%-170.89M
7.28%-107.89M
13.52%-143M
5.80%-536M
-0.38%-122.31M
9.04%-131.99M
21.35%-116.36M
Net non-operating interest income expense
-114.29%-15M
-42.31%-37M
-138.31%-12.96M
-66.33%-8.29M
3.65%-8.25M
0.33%-7M
33.33%-26M
35.73%-5.44M
57.73%-4.98M
9.05%-8.56M
Non-operating interest income
-14.29%6M
-32.43%25M
-35.17%6.51M
-45.36%5.86M
-21.71%5.79M
-20.67%7M
37.04%37M
13.30%10.04M
82.47%10.73M
24.09%7.4M
Non-operating interest expense
50.00%21M
-1.59%62M
25.76%19.47M
-9.95%14.15M
-12.02%14.04M
-11.66%14M
-4.55%63M
-10.64%15.48M
-11.06%15.71M
3.80%15.96M
Other net income (expense)
120.00%1M
71.51%-1.45M
-109.72%-365K
136.62%2.13M
-68.24%680K
-400.00%-5M
-276.74%-5.08M
277.29%3.76M
-236.81%-5.82M
Gain on sale of security
----
----
----
0.00%678K
99.77%-9K
-104.19%-157K
-380.86%-1.12M
-181.95%-1.55M
147.78%678K
-1,629.12%-3.99M
Other non- operating income (expenses)
----
120.00%1M
79.88%-934K
-133.90%-1.04M
217.00%2.14M
152.15%837K
-400.00%-5M
-436.45%-4.64M
540.20%3.08M
8.04%-1.83M
Income before tax
-22.67%-184M
-0.71%-571M
3.86%-127.69M
-34.78%-179.54M
12.80%-114M
11.88%-150M
6.90%-567M
-4.23%-132.82M
16.22%-133.21M
17.82%-130.74M
Income tax
0.00%1M
100.00%4M
126.56%870K
188.12%873K
10.37%947K
119.78%1M
200.00%2M
109.90%384K
-53.38%303K
17.21%858K
Net income
-22.52%-185M
-1.05%-575M
3.49%-128.56M
-35.12%-180.41M
12.65%-114.95M
11.53%-151M
6.26%-569M
-7.81%-133.2M
16.37%-133.52M
17.66%-131.6M
Net income continuous Operations
-22.52%-185M
-1.05%-575M
3.49%-128.56M
-35.12%-180.41M
12.65%-114.95M
11.53%-151M
6.26%-569M
-7.81%-133.2M
16.37%-133.52M
17.66%-131.6M
Minority interest income
Net income attributable to the parent company
-22.52%-185M
-1.05%-575M
3.49%-128.56M
-35.12%-180.41M
12.65%-114.95M
11.53%-151M
6.26%-569M
-7.81%-133.2M
16.37%-133.52M
17.66%-131.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-22.52%-185M
-1.05%-575M
3.49%-128.56M
-35.12%-180.41M
12.65%-114.95M
11.53%-151M
6.26%-569M
-7.81%-133.2M
16.37%-133.52M
17.66%-131.6M
Basic earnings per share
-17.20%-1.84
7.31%-5.83
7.19%-1.29
-29.29%-1.81
23.03%-1.17
22.66%-1.57
23.76%-6.29
8.55%-1.39
37.22%-1.4
32.44%-1.52
Diluted earnings per share
-17.20%-1.84
7.31%-5.83
7.19%-1.29
-29.29%-1.81
23.03%-1.17
22.66%-1.57
23.76%-6.29
8.55%-1.39
37.22%-1.4
32.44%-1.52
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue -2.16%136M20.18%673M25.89%207.28M14.65%159.93M13.24%166.5M27.72%139M29.03%560M29.50%164.65M42.27%139.49M35.75%147.03M
Operating revenue -2.16%136M20.18%673M25.89%207.28M14.65%159.93M13.24%166.5M27.72%139M29.03%560M29.50%164.65M42.27%139.49M35.75%147.03M
Cost of revenue 3.45%30M41.56%109M70.95%29.35M33.16%27.99M8.09%23M65.40%29M71.11%77M44.96%17.17M91.33%21.02M114.65%21.28M
Gross profit -3.64%106M16.77%564M20.65%177.93M11.37%131.94M14.11%143.49M20.48%110M24.16%483M27.91%147.48M36.07%118.47M27.80%125.75M
Operating expense 8.70%275M7.85%1.1B7.94%291.22M20.91%302.83M3.83%251.38M-1.42%253M6.37%1.02B13.77%269.79M7.88%250.46M-1.72%242.11M
Selling and administrative expenses 1.15%88M8.72%349M7.39%87.94M7.80%86.62M7.50%86.65M11.31%87M3.55%321M6.30%81.89M7.25%80.35M-0.98%80.6M
Research and development costs 12.65%187M7.45%750M8.18%203.28M27.10%216.21M2.00%164.74M-7.00%166M7.72%698M17.36%187.9M8.18%170.11M-2.09%161.5M
Operating profit -18.18%-169M0.19%-535M7.38%-113.28M-29.47%-170.89M7.28%-107.89M13.52%-143M5.80%-536M-0.38%-122.31M9.04%-131.99M21.35%-116.36M
Net non-operating interest income expense -114.29%-15M-42.31%-37M-138.31%-12.96M-66.33%-8.29M3.65%-8.25M0.33%-7M33.33%-26M35.73%-5.44M57.73%-4.98M9.05%-8.56M
Non-operating interest income -14.29%6M-32.43%25M-35.17%6.51M-45.36%5.86M-21.71%5.79M-20.67%7M37.04%37M13.30%10.04M82.47%10.73M24.09%7.4M
Non-operating interest expense 50.00%21M-1.59%62M25.76%19.47M-9.95%14.15M-12.02%14.04M-11.66%14M-4.55%63M-10.64%15.48M-11.06%15.71M3.80%15.96M
Other net income (expense) 120.00%1M71.51%-1.45M-109.72%-365K136.62%2.13M-68.24%680K-400.00%-5M-276.74%-5.08M277.29%3.76M-236.81%-5.82M
Gain on sale of security ------------0.00%678K99.77%-9K-104.19%-157K-380.86%-1.12M-181.95%-1.55M147.78%678K-1,629.12%-3.99M
Other non- operating income (expenses) ----120.00%1M79.88%-934K-133.90%-1.04M217.00%2.14M152.15%837K-400.00%-5M-436.45%-4.64M540.20%3.08M8.04%-1.83M
Income before tax -22.67%-184M-0.71%-571M3.86%-127.69M-34.78%-179.54M12.80%-114M11.88%-150M6.90%-567M-4.23%-132.82M16.22%-133.21M17.82%-130.74M
Income tax 0.00%1M100.00%4M126.56%870K188.12%873K10.37%947K119.78%1M200.00%2M109.90%384K-53.38%303K17.21%858K
Net income -22.52%-185M-1.05%-575M3.49%-128.56M-35.12%-180.41M12.65%-114.95M11.53%-151M6.26%-569M-7.81%-133.2M16.37%-133.52M17.66%-131.6M
Net income continuous Operations -22.52%-185M-1.05%-575M3.49%-128.56M-35.12%-180.41M12.65%-114.95M11.53%-151M6.26%-569M-7.81%-133.2M16.37%-133.52M17.66%-131.6M
Minority interest income
Net income attributable to the parent company -22.52%-185M-1.05%-575M3.49%-128.56M-35.12%-180.41M12.65%-114.95M11.53%-151M6.26%-569M-7.81%-133.2M16.37%-133.52M17.66%-131.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -22.52%-185M-1.05%-575M3.49%-128.56M-35.12%-180.41M12.65%-114.95M11.53%-151M6.26%-569M-7.81%-133.2M16.37%-133.52M17.66%-131.6M
Basic earnings per share -17.20%-1.847.31%-5.837.19%-1.29-29.29%-1.8123.03%-1.1722.66%-1.5723.76%-6.298.55%-1.3937.22%-1.432.44%-1.52
Diluted earnings per share -17.20%-1.847.31%-5.837.19%-1.29-29.29%-1.8123.03%-1.1722.66%-1.5723.76%-6.298.55%-1.3937.22%-1.432.44%-1.52
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -